Cornerstone Pharmaceuticals Email Format

Biotechnology ResearchNew Jersey, United States11-50 Employees

Cornerstone Pharmaceuticals, Inc. is a biotechnology research company based in Cranbury, New Jersey. It focuses on discovering and developing therapies that exploit distinctive metabolic processes in cancer cells, with the goal of advancing cancer treatment. Its lead candidate, CPI-613, comes from a platform focused on altered energy metabolism in cancer cells and targets enzymes involved in mitochondrial energy processes; CPI-613 is in Phase I/II trials.

The company is also developing Emulsiphan, a drug delivery technology intended to improve the safety and effectiveness of existing and new cancer therapies. Its platforms combine drug and formulation strategies that target metabolic features common to various tumor types, aiming to provide safer and more effective treatments across multiple cancers. The organization operates as a relatively small team focused on translating metabolism-based discoveries into clinical candidates.

Sign up for free to view info

Company overview Employee directory